¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¹ßÇ¥ÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

ÀϹݿ¬Á¦ ¹ßÇ¥ À¯ÀÇ»çÇ×

ÀϹݿ¬Á¦ ¹ßÇ¥ÀÚ´Â ¹Ýµå½Ã ¹ßÇ¥ ½½¶óÀ̵å(ÆÄ¿öÆ÷ÀÎÆ®)¸¦ »çÀü¿¡ Á¦ÃâÇÏ¼Å¾ß ¹ßÇ¥°¡ °¡´ÉÇÕ´Ï´Ù.
½½¶óÀ̵带 ±âÇÑ ³»¿¡ Á¦ÃâÇÏÁö ¾ÊÀ» °æ¿ì¿¡´Â ¹ßÇ¥ºÒ°¡´ÉÀ¸·Î °£ÁÖÇÕ´Ï´Ù.
¹ßÇ¥ ½½¶óÀ̵å¼ö´Â 15¸Å À̳»·Î 1Àå ´ç 10ÁÙ À̳»·Î Á¦ÀÛÇϽô °ÍÀ» ±ÇÀåÇϸç, ÁöÁ¤µÈ 10ºÐ ¹ßÇ¥½Ã°£(8ºÐ ÅäÀÇ-2ºÐ ÁúÀÇÀÀ´ä)À» Á¤È®È÷ ÁöÄÑÁֽñ⠹ٶø´Ï´Ù.

1. ÆÄÀÏ Á¦Ã⸶°¨ÀÏ : 9¿ù 22ÀÏ (¿ù)
2. ÆÄÀÏ ÇüÅ : ÆÄ¿öÆ÷ÀÎÆ®
3. Á¦Ãâ ¹æ¹ý : ppt1@ksog.org

±¸¿¬ - Àüü   /    ¸ðüžÆÀÇÇР  /    »ý½Ä³»ºÐºñÇР  /    ºÎÀÎÁ¾¾çÇР  /    ÀϹݺÎÀΰúÇÐ

[ ±¸¿¬ - ºÎÀÎÁ¾¾çÇÐ ]

2008³â 9¿ù 26ÀÏ(±Ý)

Convention Hall C (4F)
½Ã°£ ¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
ÁÂÀå : ¹é¿ø¿µ(°æ»óÀÇ´ë)
12:30~13:10 GO1 ÁÖ¿õ ÀÌÈ­ÀÇ´ë TP 53 restoration using E6/E7 siRNA potentiates therapeutic effect of cisplatin in cervical squamous cell carcinoma
GO2 À̼ºÁ¾ °¡Å縯ÀÇ´ë Distribution of human papillomavirus type 58 variants in progression of cervical dysplasia in Korean women
GO3 Àü½Ã¿ø ÀÌÈ­ÀÇ´ë The association between MCP-1 and CCR2 single nucleotide polymorphisms and cervical intraepithelial neoplasia and cervical cancer in Korean women
GO4 Á¶ÇѺ° ¿¬¼¼ÀÇ´ë Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumor marker for cervical neoplasia
ÁÂÀå : ÇãÁØ¿ë(°í·ÁÀÇ´ë)
13:10~13:50 GO5 ÀÌ´ë¿ì ¿¬¼¼ÀÇ´ë Clinical significance of tumor volume and lymph node involvement assessed by MRI in cervical cancer patients treated with concurrent chemotherapy and radiotherapy
GO6 ÀÌÀ¯¿µ ¼º±Õ°üÀÇ´ë The role of the maximal standardized uptake value (SUVmax) in positron emission tomography (PET) in early cervical cancer
GO7 ±èÀ±È¯ ¼­¿ïÀÇ´ë Adjuvant concurrent chemoradiotherapy-induced neutropenia as a prognostic factor in high-risk cervical cancer
GO8 ±èÈñ½Â ¼­¿ïÀÇ´ë Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis
ÁÂÀå : ¿À¼ºÅÃ(Àü³²ÀÇ´ë)
13:50~14:30 GO9 °­Èñ¼® ¼º±Õ°üÀÇ´ë Relative high dose topotecan combined with carboplatin in recurrent epithelial ovarian cancer (EOC)
GO10 ±è¼öÇö Æ÷õÁß¹®ÀÇ´ë Gemcitabine-carboplatin-paclitaxel combination as first-line chemotherapy in advanced ovarian cancer
GO11 À̼ºÇÏ °¡Å縯ÀÇ´ë Serial pattern of CA125 levels as a predictive value of recurrence in advanced epithelial ovarian cancer
GO12 ±è¹Ì°æ ¼­¿ïÀÇ´ë Neoadjuvant chemotherapy for stage III or IV ovarian cancer : Effects on optimal debulking rates and survival
14:30~15:00   Coffee Break
ÁÂÀå : ±èÀåÈí(°¡Å縯ÀÇ´ë)
15:00~15:40 GO13 ¹ÚÁ¤¿­ ¿ï»êÀÇ´ë Comparison of laparoscopic radical hysterectomy and abdominal radical hysterectomy for stage IA2-IIA cervical cancer: A matched case-control study
GO14 À±Á¾¼÷ °¡Å縯ÀÇ´ë Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer
GO15 ¹ÚÁø¿µ ¾ÆÁÖÀÇ´ë Are the adjuvant chemoradiation using 3 ~ 4 cycles of 5-FU/Cisplatin adequate enough for all cervical cancer patients with high risk for treatment failure after radical hysterectomy?
GO16 °­¿ì´ë Àü³²ÀÇ´ë A clinical analysis of abnormal cervical cancer screening in private clinics
ÁÂÀå : ·ùöÈñ(ÀüºÏÀÇ´ë)
15:40~16:20 GO17 ±è±âÇü ºÎ»êÀÇ´ë AZD6244 (ARRY-142886), a Potent MEK 1/2 Inhibitor, induces Selective Growth inhibition in Epithelial Ovarian cancer cells
GO18 À̼±ÁÖ °Ç±¹ÀÇ´ë Combined effect of protein kinase B inhibitor or extracellular signal-regulated kinase inhibitor against farnesyltransferase inhibition-induced apoptosis in SiHa cells
GO19 Àü¼· ¼øõÇâÀÇ´ë Promoter methylation of runx3 gene in endometrial cancer
GO20 ½Å¼ÒÁø °è¸íÀÇ´ë Enhanced expression of transcription factor Nrf2 by isoliquiritigenin (ISL) in uterine leiomyoma cells.
ÁÂÀå : ±è¼®Çö(¼­¿ïÀÇ´ë)
16:20~17:00 GO21 ÇÑÈ£¼· °üµ¿ÀÇ´ë Laparoscopic-assisted vaginal hysterectomy vs. abdominal hysterectomy in endometrial cancer
GO22 Àü¿µÀº ¿¬¼¼ÀÇ´ë Leukocyte differential count as a diagnostic and prognostic factor in endometrial cancer
GO23 ±è¹ÎÁ¤ ¼­¿ïÀÇ´ë What do Korean breast cancer patients need for sexual activity?
GO24 ±â°æµµ °æÈñÀÇ´ë Pulmonary toxicity after a quick course of combinatorial vincristine, bleomycin, and cisplatin neoadjuvant chemotherapy in cervical cancer